Progenitor cells |
Pancreatic stem-cell population, self-regeneration of pancreatic islets |
No direct evidence of presence in humans |
[37,38,39] |
Transdifferentiation |
Cell availability, possibility for personalized cell therapy |
Low differentiation efficiency, high cell heterogeneity, functional immaturity, low GSIS, absence of key beta cell markers |
[17,18,19,20,21,22,23,24,25,26] |
Direct differentiation (ESCs, PSCs) |
Usage of undifferentiated cells, mimicking embryological development, relatively robust GSIS, low heterogeneity, possibility for personalized cell therapy |
Signs of functional immaturity, differences in metabolic pathways |
[32,33,34,35,36] |
Direct differentiation protocol
|
Advancement
|
D’Amour et al., 2005 [16] |
Efficient differentiation of hESCs to definitive endoderm |
Chen et al., 2009 [29] |
Generation of pancreatic PDX1+-progenitors from hESCs |
Nostro et al., 2011 [30] |
Roles of TGF-b, WNT, nodal/activin A, and BMP (bone morphogenetic protein) signaling in the pancreatic lineage cell specification |
Rezania et al., 2014 [32]; Pagliuca et al., 2014 [33] |
Generation of stem cell-derived beta cells closely resembling native beta cells |
Russ et al., 2015 [34] |
Omission of BMP inhibitors during pancreatic specification results in higher yield of PDX1+/NKX6.1+-cells |
Nair et al., 2019 [35] |
Endocrine cell clustering mimics pancreatic organogenesis and promotes beta cell differentiation |
Liu et al., 2021 [36] |
New combination of chemicals and 3D pancreatic progenitor clusters promote beta cell functions |